Markets:

Overview

News

Currencies

International

Treasuries

Cue Biopharma, Inc. - Common Stock (NQ:CUE)

32.54 +2.69 (+9.01%)

Streaming Delayed Price Updated: 1:52 PM EDT, May 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cue Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Cue Biopharma Enters into a Strategic Collaboration and Option Agreement with Ono Pharmaceutical for CUE-401

February 22, 2023

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma’s Therapeutic Immuno-STAT Biologics to be Featured in Oxford University Presentation at the 67th Biophysical Society Annual Meeting

February 16, 2023

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma Announces the Appointment of Dr. Rafi Ahmed to its Scientific Advisory Board

February 16, 2023

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma to Present at Two February 2023 Scientific Conferences

February 01, 2023

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma Announces Chief Medical Officer Transition

January 23, 2023

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences

November 22, 2022

From Cue Biopharma, Inc.

Via GlobeNewswire

Public Ventures LLC Completes First Public Company Financing as a Broker-Dealer for Cue Biopharma, Inc. (Nasdaq:CUE)

November 17, 2022

Via ACCESSWIRE

Cue Biopharma Reports Third Quarter 2022 Financial Results

November 14, 2022

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing

November 14, 2022

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma Presents New Positive Data from Ongoing Phase 1 Trial of CUE-101 in Combination with KEYTRUDA(R) for Recurrent/Metastatic HPV+ Head and Neck Cancer at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

November 10, 2022

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in November

November 09, 2022

From Cue Biopharma, Inc.

Via GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast

November 07, 2022

From Cue Biopharma, Inc.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 24, 2022

Good morning, traders! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning!

Via InvestorPlace

Why Soluna Holdings Shares Are Trading Sharply Lower; Here Are 38 Stocks Moving Premarket ↗

October 24, 2022

Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) rose 70.8% to $0.41 in pre-market trading. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.

Via Benzinga

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

October 05, 2022

From Cue Biopharma, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 04, 2022

Gainers

Via Benzinga

Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session ↗

October 04, 2022

Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday.

Via Benzinga

Cue Biopharma Granted FDA Fast Track Designation for CUE-101 for the Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

October 04, 2022

From Cue Biopharma, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 01, 2022

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 22, 2022

Via Benzinga

Cue Biopharma Shares Decline Following Initial-Stage Metastatic Cancer Study Kicks-off ↗

August 22, 2022

Cue Biopharma (NASDAQ: CUE) has dosed the first patient in a Phase 1 dose escalation study evaluating CUE-102 for the treatment of patients with Wilms' Tumor 1 (WT1)-positive recurrent/metastatic...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

June 28, 2022

On Tuesday, 87 companies hit new 52-week lows.

Via Benzinga

Cue Biopharma's Return On Capital Employed Overview ↗

June 14, 2022

Benzinga Pro data, Cue Biopharma (NASDAQ:CUE) reported Q1 sales of $1.00 million. Earnings fell to a loss of $14.26 million, resulting in a 70.02% decrease from last quarter.

Via Benzinga

FDA Accepts IND for Cue Biopharma's CUE-102 in the treatment of Wilms' Tumor 1 (WT1) ↗

May 11, 2022

Cue Biopharma, Inc. (NASDAQ: CUE) received the U.S. Food and Drug Administration (FDA) acceptance of the Investigational New Drug (IND) application for the evaluation of CUE-102 in the treatment of...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 06, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 05, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) shares moved upwards by 163.3% to $5.95 during Tuesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

Looking Into Cue Biopharma's Return On Capital Employed ↗

March 18, 2022

According to data from Benzinga Pro, during Q4, Cue Biopharma's (NASDAQ:CUE) reported sales totaled $8.25 million. Despite a 35.47% increase in earnings, the company posted a loss...

Via Benzinga

64 Biggest Movers From Yesterday ↗

March 18, 2022

Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 02, 2022

Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

February 08, 2022

Tuesday's session saw 109 companies set new 52-week lows. Interesting Points From Today's 52-Week Highs And Lows: The largest company in terms of market cap...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

CONCORD NEWS IN YOUR INBOX: SIGN UP HERE

Cue Biopharma, Inc. - Common Stock (NQ:CUE)

All News about Cue Biopharma, Inc. - Common Stock

The Newspapers of New England Family

We continue to need local support from our readers

Enjoying the Concord Monitor?

CONCORD NEWS IN YOUR INBOX: SIGN UP HERE

Cue Biopharma, Inc. - Common Stock (NQ:CUE)

All News about Cue Biopharma, Inc. - Common Stock

Sign in